Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Common and contrasting effects of 5-HTergic signaling in pyramidal cells and SOM interneurons of the mouse cortex
    Published on 2024-11-06
    2 years ago
  • Improved patient identification by incorporating symptom severity in deep learning using neuroanatomic images in first episode schizophrenia
    Published on 2024-11-05
    2 years ago
  • In memoriam: Klaus A Miczek, PhD
    Published on 2024-11-03
    2 years ago
  • Orexinergic modulation of chronic jet lag-induced deficits in mouse cognitive flexibility
    Published on 2024-10-29
    2 years ago
  • PACAP regulates neuroendocrine and behavioral stress responses via CRF-containing neurons of the rat hypothalamic paraventricular nucleus
    Published on 2024-10-28
    2 years ago
  • Is the stereoisomer R-MDMA a safer version of MDMA?
    Published on 2024-10-24
    2 years ago
  • Extended course accelerated intermittent theta burst stimulation as a substitute for depressed patients needing electroconvulsive therapy
    Published on 2024-10-23
    2 years ago
« Previous 1 … 77 78 79 80 81 … 143 Next »
Journal of Psychopharmacology
  • Clinical correlates of early onset antipsychotic treatment resistance
    Published on 2022-10-21
    4 years ago
  • Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia
    Published on 2022-10-21
    4 years ago
  • Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review
    Published on 2022-10-20
    4 years ago
  • D2-like receptor activation by intranasal dopamine attenuates fear responses induced by electrical stimulation of the dorsal periaqueductal grey matter, but fails to reduce aversion to pit vipers and T-maze performance
    Published on 2022-10-14
    4 years ago
  • Efficacy of aripiprazole as adjunctive therapy in major depressive disorder with somatic symptoms: A randomized, double-blind, placebo-controlled trial with clinical and electroencephalography evidence
    Published on 2022-10-14
    4 years ago
  • Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze
    Published on 2022-10-14
    4 years ago
  • Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool
    Published on 2022-10-14
    4 years ago
« Previous 1 … 77 78 79 80 81 … 154 Next »
European Neuropsychopharmacology
  • Rates of psychotropic medicine prescribing in paediatric populations in Australian general practice from 2000-2016
    Published on 2022-11-24
    4 years ago
  • Effect of psychotropics on the risk of COVID-19 in Middle-Aged and Older Adults
    Published on 2022-11-24
    4 years ago
  • Sexual orientation as an important factor in personalized medicine
    Published on 2022-11-14
    4 years ago
  • Single dose S-ketamine rescues transcriptional dysregulation of Mtor and Nrp2 in the prefrontal cortex of FSL rats 1hour but not 14 days post dosing
    Published on 2022-11-12
    4 years ago
  • Delay in pharmacological treatment of autistic children after recognition of the disorder
    Published on 2022-11-11
    4 years ago
  • Ayahuasca’s therapeutic potential: What we know – and what not
    Published on 2022-11-08
    4 years ago
  • Antidepressant discontinuation syndrome: A state-of-the-art clinical review
    Published on 2022-11-05
    4 years ago
« Previous 1 … 77 78 79 80 81 … 170 Next »

   Pharma Pub